Reach the investors backing rounds like this
Backed by Viking Global Investors, MVM Partners +4 more · verified emails and LinkedIn on Datapile
GT Medical Technologies Raises $100M Series E to Advance Brain Tumour Therapy - Ventureburn
GT Medical Technologies develops innovative treatments for brain tumor patients, focusing on improving survival outcomes and quality of life. Their flagship product, GammaTile therapy, delivers immediate targeted radiation at the tumor site during surgery, aiming to reduce tumor regrowth and limit exposure to healthy brain tissue.
GT Medical Technologies Raises $100M Series E to Advance Brain Tumour Therapy Ventureburn
| Nov 01, 2026 | Hightouch | $40.0M | Series B | United States |
| Oct 30, 2026 | Pluto Aerospace | $2.5M | Seed | United States |
| Oct 30, 2026 | Audio Chateau Records | $9.0M | Series A | United States |
| Oct 30, 2026 | AvalonX | $10.0M | — | United States |
You just read who funded GT Medical Technologies. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.